Literature DB >> 10725698

Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages.

S Akashi1, R Shimazu, H Ogata, Y Nagai, K Takeda, M Kimoto, K Miyake.   

Abstract

The human MD-2 molecule is associated with the extracellular domain of human Toll-like receptor 4 (TLR4) and greatly enhances its LPS signaling. The human TLR4-MD-2 complex thus signals the presence of LPS. Little is known, however, about cell surface expression and LPS signaling of the TLR4-MD-2 complex in vivo. We cloned mouse MD-2 molecularly and established a unique mAb MTS510, which reacted selectively with mouse TLR4-MD-2 but not with TLR4 alone in flow cytometry. Mouse MD-2 expression in TLR4-expressing cells enhanced LPS-induced NF-kappaB activation, which was clearly inhibited by MTS510. Thioglycolate-elicited peritoneal macrophages expressed TLR4-MD-2, which was rapidly down-regulated in the presence of LPS. Moreover, LPS-induced TNF-alpha production by peritoneal macrophages was inhibited by MTS510. Collectively, the TLR4-MD-2 complex is expressed on macrophages in vivo and senses and signals the presence of LPS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725698     DOI: 10.4049/jimmunol.164.7.3471

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  114 in total

Review 1.  The biology of endotoxin.

Authors:  H Heine; E T Rietschel; A J Ulmer
Journal:  Mol Biotechnol       Date:  2001-11       Impact factor: 2.695

Review 2.  Toll receptors: a central element in innate immune responses.

Authors:  Thierry Vasselon; Patricia A Detmers
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Beneficial effect of a CXCR4 agonist in murine models of systemic inflammation.

Authors:  Hongkuan Fan; Donald Wong; Sarah H Ashton; Keith T Borg; Perry V Halushka; James A Cook
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

4.  Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide.

Authors:  Luis A Augusto; Monique Synguelakis; Jan Johansson; Thierry Pedron; Robert Girard; Richard Chaby
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

5.  Identification of a novel human MD-2 splice variant that negatively regulates Lipopolysaccharide-induced TLR4 signaling.

Authors:  Pearl Gray; Kathrin S Michelsen; Cherilyn M Sirois; Emily Lowe; Kenichi Shimada; Timothy R Crother; Shuang Chen; Constantinos Brikos; Yonca Bulut; Eicke Latz; David Underhill; Moshe Arditi
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

6.  Eradication of the commensal intestinal microflora by oral antimicrobials interferes with the host response to lipopolysaccharide.

Authors:  T Umenai; H Hirai; N Shime; T Nakaya; T Asahara; K Nomoto; M Kita; Y Tanaka; J Imanishi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-20       Impact factor: 3.267

7.  ß-adrenergic stimulation increases macrophage CD14 expression and E. coli phagocytosis through PKA signaling mechanisms.

Authors:  Kuzhali Muthu; Li-K He; Andrea Szilagyi; Patrick Strotmon; Richard L Gamelli; Ravi Shankar
Journal:  J Leukoc Biol       Date:  2010-07-19       Impact factor: 4.962

Review 8.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 9.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

10.  MD-2 is necessary for the toll-like receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface.

Authors:  Takahiro Ohnishi; Masashi Muroi; Ken-Ichi Tanamoto
Journal:  Clin Diagn Lab Immunol       Date:  2003-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.